The global bilirubin blood test market is set for significant growth, with market size expected to reach USD 2.30 billion by 2030. This represents a robust compound annual growth rate (CAGR) of 6.32% during the forecast period from 2023 to 2030. The market's expansion is driven by advancements in diagnostic technologies, increasing prevalence of liver diseases, and the residual impacts of the COVID-19 pandemic.

Key Players

The major Key players are Koninklijke Philips N.V. (Noord-Holland), Beckman Coulter, Inc, Thermo Fisher Scientific Inc, Randox Laboratories Ltd, Hoffmann-La Roche AG, Dragerwerk AG & Co. KGaA, Ginevri, Advanced Instruments, Reichert, Inc, Instrumentation Laboratory, AVI Healthcare Pvt. Ltd, and other players.

Get Sample PDF @ https://www.snsinsider.com/sample-request/3245 

Impact of COVID-19:

The COVID-19 pandemic has had a dual impact on the bilirubin blood test market. While the initial outbreak caused disruptions in healthcare services, delaying non-urgent diagnostics, the ongoing pandemic has underscored the importance of regular health monitoring. Post-pandemic, there has been a resurgence in demand for diagnostic tests, including bilirubin blood tests, as healthcare systems adapt to new norms and prioritize early disease detection and management.

KEY MARKET SEGMENTS

By Test Type

• Total Serum Bilirubin (Tsb)

• Direct/Conjugated Bilirubin Test

• Indirect/Unconjugated Bilirubin Test

By Product Type

• Two Types

• Namely

• Consumables

• Instruments

By Application

• Newborn Children

• Adults

By End-Users

• Diagnostics Centers

• Pathological Labs

• Hospitals

Latest Trends:

Technological Innovations: Advancements in point-of-care testing and automated analyzers are enhancing the accuracy and efficiency of bilirubin blood tests, making them more accessible and reliable.

Integration with Electronic Health Records (EHRs):

The incorporation of bilirubin testing data into EHRs is improving patient management and facilitating better clinical decision-making.

Home Testing Kits:

The development and availability of home testing kits for bilirubin levels are increasing, catering to the growing demand for convenient and timely diagnostic options.

Market Growth Factors:

Rising Prevalence of Liver Diseases:

Increasing incidences of liver disorders, such as hepatitis and cirrhosis, are driving the demand for bilirubin blood tests, which are crucial for diagnosing and monitoring these conditions.

Neonatal Care Needs:

Bilirubin tests are essential for detecting and managing neonatal jaundice, a common condition in newborns, further fueling market growth.

Healthcare Awareness and Access:

Improved healthcare infrastructure and rising awareness about regular health check-ups are contributing to the market's expansion.

Restraining Factors:

High Cost of Advanced Testing Equipment:

The high cost associated with advanced bilirubin testing equipment can be a barrier, particularly in low-income regions.

Regulatory Challenges:

Stringent regulatory requirements and lengthy approval processes for new diagnostic devices can impede market growth.

Regional Insights:

North America:

Dominates the bilirubin blood test market due to advanced healthcare infrastructure, high awareness levels, and significant investments in healthcare R&D.

Europe:

Holds a substantial market share, driven by well-established healthcare systems and increasing prevalence of liver diseases.

Asia-Pacific:

Expected to witness the fastest growth, fueled by rising healthcare expenditure, increasing incidence of liver disorders, and improving diagnostic facilities.

Key Industry Developments:

Product Launches and Innovations:

Leading companies are focusing on launching innovative products and improving existing technologies to enhance the accuracy and convenience of bilirubin testing.

Strategic Partnerships:

Collaborations between diagnostic companies and healthcare providers are facilitating the development and adoption of advanced testing solutions.

Regulatory Approvals:

Recent regulatory approvals for new bilirubin testing devices are expanding the market's potential and improving patient outcomes.

Other Trending Report

Wheelchair Market

Lancet Market

HLA Typing Market

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand – Head of Business Development & Strategy

info@snsinsider.com

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

Website: https://www.snsinsider.com